BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 27737011)

  • 1. 25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma.
    Danilovic DL; Ferraz-de-Souza B; Fabri AW; Santana NO; Kulcsar MA; Cernea CR; Marui S; Hoff AO
    PLoS One; 2016; 11(10):e0164550. PubMed ID: 27737011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum 25-Hydroxyvitamin D Level Does Not Affect the Aggressiveness and Prognosis of Papillary Thyroid Cancer.
    Ahn HY; Chung YJ; Park KY; Cho BY
    Thyroid; 2016 Mar; 26(3):429-33. PubMed ID: 26739552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].
    Wang SX; She ZQ; An CM; Zhang XW; Li ZJ; Tang PZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 51(4):277-81. PubMed ID: 27095720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between Pre-Operative 25-Hydroxyvitamin D Levels and Poor Prognostic Factors for Papillary Thyroid Cancer.
    Abuduwaili M; Xing Z; Xia B; Fei Y; Zhu J; Su A
    J Invest Surg; 2022 May; 35(5):1076-1082. PubMed ID: 34865593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low serum 25 hydroxyvitamin D is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer.
    Kim JR; Kim BH; Kim SM; Oh MY; Kim WJ; Jeon YK; Kim SS; Lee BJ; Kim YK; Kim IJ
    Thyroid; 2014 Nov; 24(11):1618-24. PubMed ID: 25133449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma.
    Xia Q; Dong S; Bian PD; Wang J; Li CJ
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment of 25(OH)D3, concentration levels in patients with papillary thyroid cancer compared to patients with Hashimoto's thyroiditis].
    Lizis-Kolus K; Hubalewska-Dydejczyk A; Trofimiuk-Muldnerz M; Sowa-Staszczak A; Kowalska A
    Przegl Lek; 2013; 70(11):920-5. PubMed ID: 24697030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between preoperative thyrotrophin and clinicopathological and aggressive features of papillary thyroid cancer.
    Tam AA; Ozdemir D; Aydın C; Bestepe N; Ulusoy S; Sungu N; Ersoy R; Cakir B
    Endocrine; 2018 Mar; 59(3):565-572. PubMed ID: 29374347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroglobulin antibodies could be a potential predictive marker for papillary thyroid carcinoma.
    Vasileiadis I; Boutzios G; Charitoudis G; Koukoulioti E; Karatzas T
    Ann Surg Oncol; 2014 Aug; 21(8):2725-32. PubMed ID: 24595799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of association between high serum thyroid-stimulating hormone level and risk of papillary thyroid microcarcinomas.
    Sohn SY; Kim HJ; Jang HW; Kim SW; Chung JH
    Head Neck; 2014 Jan; 36(1):43-6. PubMed ID: 23728859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
    Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer.
    Jonklaas J; Danielsen M; Wang H
    Thyroid; 2013 Sep; 23(9):1079-86. PubMed ID: 23350941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma.
    Ahn D; Sohn JH; Kim JH; Shin CM; Jeon JH; Park JY
    Am J Otolaryngol; 2013; 34(4):312-9. PubMed ID: 23357595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
    Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
    Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.
    Chen L; Zhu Y; Zheng K; Zhang H; Guo H; Zhang L; Wu K; Kong L; Ruan W; Hu J; Zhang X; Chen X
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1035-1042. PubMed ID: 28204971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of VEGF-C, VEGF-D and VEGFR-3 levels combined with serum TSH in diagnosis of papillary thyroid carcinoma].
    Huang J; Li Y; Xue G; Zhang W; Li S; Zhang J; Wu J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1814-7, 1821. PubMed ID: 25537909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results.
    Moon JH; Kim YI; Lim JA; Choi HS; Cho SW; Kim KW; Park HJ; Paeng JC; Park YJ; Yi KH; Park DJ; Kim SE; Chung JK
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1061-8. PubMed ID: 23393171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
    Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
    Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role.
    Fiore E; Rago T; Provenzale MA; Scutari M; Ugolini C; Basolo F; Di Coscio G; Berti P; Grasso L; Elisei R; Pinchera A; Vitti P
    Endocr Relat Cancer; 2009 Dec; 16(4):1251-60. PubMed ID: 19528244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of SPECT/CT Lymphoscintigraphy and Radioguided Sentinel Lymph Node Biopsy in Managing Papillary Thyroid Cancer.
    Cabrera RN; Chone CT; Zantut-Wittmann DE; Matos PS; Ferreira DM; Pereira PS; Ribeiro MP; Santos AO; Ramos CD; Crespo AN; Etchebehere EC
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):834-41. PubMed ID: 27366869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.